Human Reproduction, Vol. 15, No. 7, 1509-1514,
July 2000
© 2000 European Society of Human Reproduction and Embryology
Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding
1 Department of Reproductive Science and Medicine, Imperial College School of Medicine at St Mary's, Norfolk Place W2 1PG, London, UK and 2 Electron Microscopy Unit and 3 Sydney Centre for Reproductive Health Research, Department of Obstetrics and Gynaecology, University of Sydney, NSW 2006, Australia
The aim of this study was to develop an objective test for superficial endometrial vascular fragility at hysteroscopy, and to apply this test to women using Norplant® for contraception and to women with ovulatory dysfunctional uterine bleeding (DUB). A prospective observational study was carried out in 34 Norplant users and 20 women with menorrhagia due to ovulatory DUB. Superficial endometrial vascular fragility was assessed at hysteroscopy by observing the source and extent of frank and subepithelial bleeding during controlled collapse and redistension of the uterine cavity. Superficial endometrial blood vessels were more fragile in Norplant users compared to women with DUB (
2 = 11.60, P = 0.02). Superficial endometrial petechiae (
2 = 37.9, P < 0.0001) and ecchymoses (
2 = 42.2, P = 0.0001) were more frequently observed in the Norplant users than in the menorrhagia group. In Norplant users, superficial endometrial vascular fragility was increased in those with frequent bleeding or spotting during the past 30 days (
2 = 6.15, P = 0.01), and in those who were examined during a bleeding episode (
2 = 5.3, P = 0.02). Fragility was increased in the menorrhagia group during the perimenstrual period (days 24 to 05;
2 = 12.83, P = 0.01). There was no obvious relationship between subepithelial bleeding and circulating concentrations of oestradiol and progesterone.
Key words: breakthrough bleeding/contraception/endometrium/progestogen/vascular fragility
4 To whom correspondence should be addressed at: Imperial College School of Medicine at St Mary's, Department of Obstetrics and Gynaecology, Norfolk Place, London W2 1PG, UK. E-mail: m.hickey{at}ic.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M.-L. Alvarez Gonzalez, F. Frankenne, C. Galant, E. Marbaix, J.-M. Foidart, M. Nisolle, and A. Beliard Mixed origin of neovascularization of human endometrial grafts in immunodeficient mouse models Hum. Reprod., September 1, 2009; 24(9): 2217 - 2224. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Weisberg, M. Hickey, D. Palmer, V. O'Connor, L.A. Salamonsen, J.K. Findlay, and I.S. Fraser A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users Hum. Reprod., August 1, 2009; 24(8): 1852 - 1861. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Alvarez Gonzalez, C. Galant, F. Frankenne, M. Nisolle, S. Labied, J.-M. Foidart, E. Marbaix, and A. Beliard Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium Hum. Reprod., March 1, 2009; 24(3): 697 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hickey, D.A. Doherty, I.S. Fraser, D.M. Sloboda, and L.A. Salamonsen Why does menopausal hormone therapy lead to irregular uterine bleeding? Changes to endometrial blood vessels Hum. Reprod., April 1, 2008; 23(4): 912 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stephanie, S. Labied, S. Blacher, F. Frankenne, C. Munaut, V. Fridman, A. Beliard, J.-M. Foidart, and M. Nisolle Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., December 1, 2007; 22(12): 3084 - 3091. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Peloggia, C. A. Petta, L. Bahamondes, M. Oliveira-Ribeiro, J. Zhang, and L. Salamonsen Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system Hum. Reprod., May 1, 2006; 21(5): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Jain, A. Li, W. Yang, P. Minoo, and J. C. Felix Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate Hum. Reprod., March 1, 2006; 21(3): 798 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.A.W. Rogers, F. Martinez, J.E. Girling, F. Lederman, L. Cann, E. Farrell, F. Tresserra, and N. Patel Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding Hum. Reprod., December 1, 2005; 20(12): 3341 - 3347. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Jones, N. B. Morison, N. J. Hannan, H. O.D. Critchley, and L. A. Salamonsen Chemokine expression is dysregulated in the endometrium of women using progestin-only contraceptives and correlates to elevated recruitment of distinct leukocyte populations Hum. Reprod., October 1, 2005; 20(10): 2724 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chwalisz, M. C. Perez, D. DeManno, C. Winkel, G. Schubert, and W. Elger Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis Endocr. Rev., May 1, 2005; 26(3): 423 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Pritts, I. P. Ryan, M. D. Mueller, D. I. Lebovic, J. L. Shifren, C. J. Zaloudek, A. P. Korn, P. D. Darney, and R. N. Taylor Angiogenic Effects of Norplant Contraception on Endometrial Histology and Uterine Bleeding J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2142 - 2147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chwalisz, W. Elger, T. Stickler, C. Mattia-Goldberg, and L. Larsen The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women Hum. Reprod., April 1, 2005; 20(4): 1090 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.A. Roopa, A. Loganath, and K. Singh The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium Hum. Reprod., September 1, 2003; 18(9): 1809 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hickey, G. Pillai, J.M. Higham, M. Sullivan, D. Horncastle, D. Doherty, and G. Stamp Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding Hum. Reprod., May 1, 2003; 18(5): 1100 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hickey and I.S. Fraser Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding Hum. Reprod., September 1, 2002; 17(9): 2428 - 2434. [Abstract] [Full Text] [PDF] |
||||


